Tiger Brokers

Select Medical Q4 income from continuing operations before other income and expense jumps 3.03x to USD 63.9 million

Reuters
13 hours ago
<a href="https://laohu8.com/S/SEM.WI">Select Medical</a> Q4 income from continuing operations before other income and expense jumps 3.03x to USD 63.9 million

Select Medical reported Q4 2025 revenue of USD 1.40 billion (+6.4%) and income from continuing operations, net of tax, of USD 37.74 million, with adjusted EBITDA of USD 104.66 million. Q4 diluted EPS from continuing operations was USD 0.16; adjusted EPS from continuing operations was USD 0.16. For FY 2025, Select Medical posted revenue of USD 5.45 billion (+5.1%) and income from continuing operations, net of tax, of USD 214.53 million (+65.0%), while adjusted EBITDA was USD 493.18 million. FY diluted EPS from continuing operations was USD 1.16 and adjusted EPS from continuing operations was USD 1.16. Segment highlights in Q4 2025 included critical illness recovery hospital revenue of USD 629.72 million (+4.9%) with adjusted EBITDA of USD 66.41 million (+5.3%); rehabilitation hospital revenue of USD 339.18 million (+15.2%) with adjusted EBITDA of USD 69.20 million (+11.1%); and outpatient rehabilitation revenue of USD 324.56 million (+1.6%) with adjusted EBITDA of USD 11.18 million. Select Medical reiterated its 2026 outlook, guiding for revenue of USD 5.6 billion to USD 5.8 billion, adjusted EBITDA of USD 520 million to USD 540 million, and fully diluted EPS of USD 1.22 to USD 1.32. The board declared a cash dividend of USD 0.0625 per share, payable on or about March 12, 2026, to holders of record as of March 2, 2026. The company also noted it received a non-binding take-private proposal from Executive Chairman Robert A. Ortenzio at USD 16.00 to USD 16.20 per share and said an independent special committee is reviewing the proposal and other strategic alternatives.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Select Medical Holdings Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: 202602191630PR_NEWS_USPR_____PH91562) on February 19, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10